Inactive Instrument

All News Pharmadax Inc.

Equities

Pharmadax Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	11/23/11	CI
Pharmadax Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Pharmadax Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	12/22/12	CI
Pharmadax Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Sihuan Pharmaceutical : Metoprolol Succinate Gets Approval for Registration in China	29/21/29	MT
Pharmadax Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	13/21/13	CI
Sihuan Pharmaceutical : Unit Secures Exclusive Marketing Rights for Heart Disease Drug; Shares Jump 4%	28/21/28	MT
Pharmadax Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	29/21/29	CI
Pharmadax Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	01/20/01	CI
Pharmadax Inc. Reports Earnings Results for the Half Year Ended June 30, 2020	13/20/13	CI
Pharmadax Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	29/20/29	CI
Pharmadax Inc. Reports Earnings Results for the Half Year Ended June 30, 2019	13/19/13	CI
Pharmadax Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	26/19/26	CI
PharmaDax Inc. Receives FDA Approval for Generic Version of Seroquel XR®	16/17/16	CI
Coland Holdings Limited completed the acquisition of additional 4.08% stake in Pharmadax Inc..	31/13/31	CI
Coland Holdings Limited agreed to acquire an additional 4.08% stake in Pharmadax Inc. for TWD 260 million.	14/13/14	CI

No results for this search